> The FDA has accepted Sirion Therapeutics' NDA for ganciclovir ophthalmic gel as a treatment for herpetic keratitis, an eye disease. Release l Story
> Oculus Innovative Sciences says it has forged an agreement with VetCure on a $3 million investment, which it says will keep the company on track to profitability in 12 months. Release
> The new antiepileptic drug Vimpat (lacosamide) demonstrated significantly fewer seizures in adult partial-onset epilepsy patients whose seizures were inadequately controlled despite taking up to three other AEDs, according to a Phase III clinical study published online in Epilepsia. Release
> It's that time of year again: Earnings season. Yesterday, all the deal hoopla squeezed out Pfizer and Wyeth's results, but we have them for you today. Plus, get the numbers on Amgen and Bristol-Myers Squibb. Report
> Malaria experts are hailing Novartis for launching a child-friendly version of its Coartem treatment. The new med contains the same dosage and ingredients as the adult version, but it's sweet-tasting and disperses quickly in small amounts of water. Report
> BioMarin has received preferred shares of La Jolla Pharmaceutical as part of their licensing deal regarding Riquent. Report
> The FDA's decision to allow Geron to launch the first clinical trial of an embryonic stem cell therapy has sent a jolt of optimism--along with an undercurrent of fresh anxiety--coursing through the fledgling stem cell field. Report
> The FDA is putting the anti-clotting drug Plavix under its safety microscope. The question: Whether the second-best-selling drug in the U.S. is less effective in some patients. Report
> Researchers have been spending time and money trying to find a therapy that can have the same tonic effect as a sharp reduction in calories. Now German scientists say that a 30 percent reduction in caloric intake among overweight seniors can significantly improve memory and thinking skills. Report
And Finally.... The science of the very small may deliver a new technology that can constantly monitor a person's blood sugar level and alert them when they need an insulin shot. The nanosensors would be injected under the skin, much like dye for a tattoo. Rising glucose levels in the blood would trigger a fluorescent response under an infrared light, alerting a patient if they need a shot after a meal. And the same nanosensor could be used to detect and track levels of other chemicals, such as sodium, which could be used to detect dehydration. Article